GLEM LIN MXR 25/5/1000MG TAB NEW

GLEM LIN MXR is a triple-action diabetes management tablet combining three active ingredients: empagliflozin, linagliptin, and metformin HCl. This fixed-dose combination is designed to help regulate blood sugar levels in patients with type 2 diabetes through multiple mechanisms—enhancing insulin secretion, improving insulin sensitivity, and promoting glucose excretion through urine. Each tablet contains 25mg empagliflozin, 5mg linagliptin, and 1000mg metformin HCl for consistent dosing. Ideal for patients requiring multi-drug therapy to achieve better glycemic control. Always use as directed by your healthcare provider.